J&J Files 8-K on Debt Issuances

TL;DR

J&J dropped an 8-K on a bunch of new debt notes – check the rates and maturities.

AI Summary

On September 20, 2024, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include notes due in 2024, 2028, 2032, 2035, 2036, and 2044, with coupon rates ranging from 1.150% to 5.50%. This filing is primarily for informational purposes regarding their ongoing financing activities.

Why It Matters

This filing provides transparency into Johnson & Johnson's capital structure and ongoing debt management, which can influence investor perception of its financial health and borrowing costs.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of debt issuances and does not indicate any unusual financial distress or significant new risks.

Key Numbers

• 5.50% — Notes Due 2024 Coupon Rate (Represents the highest coupon rate disclosed for the notes.)
• 1.150% — Notes Due Nov 2028 Coupon Rate (Represents the lowest coupon rate disclosed for the notes.)

Key Players & Entities

• JOHNSON & JOHNSON (company) — Registrant
• September 20, 2024 (date) — Report Date
• 5.50% (dollar_amount) — Coupon rate for notes due 2024
• 1.150% (dollar_amount) — Coupon rate for notes due November 2028
• 3.20% (dollar_amount) — Coupon rate for notes due November 2032
• 1.650% (dollar_amount) — Coupon rate for notes due 2035
• 3.350% (dollar_amount) — Coupon rate for notes due November 2036
• 3.550% (dollar_amount) — Coupon rate for notes due November 2044

FAQ

From the Filing

0000200406-24-000083.txt : 20240920 0000200406-24-000083.hdr.sgml : 20240920 20240920161926 ACCESSION NUMBER: 0000200406-24-000083 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240920 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240920 DATE AS OF CHANGE: 20240920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 241313624 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20240920.htm 8-K jnj-20240920 0000200406 false 0000200406 2024-09-20 2024-09-20 0000200406 us-gaap:CommonStockMember 2024-09-20 2024-09-20 0000200406 jnj:A5.50NotesDue2024Member 2024-09-20 2024-09-20 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-09-20 2024-09-20 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-09-20 2024-09-20 0000200406 jnj:A1.650NotesDue2035Member 2024-09-20 2024-09-20 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-09-20 2024-09-20 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-09-20 2024-09-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  September 20, 2024 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 3.20% Notes Due November 2032 JNJ32 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange 3.350% Notes Due November 2036 JNJ36A New York Stock Exchange 3.550% Notes Due November 2044 JNJ44 New York Stock Exchange Item 7.01 Regulation FD Disclosure On September 20, 2024, the Company announced that its subsidiary